Did you miss our Conference Call on IBM? Watch the replay here. HIDE

Isis Pharmaceuticals (ISIS)

Add to Watchlists Create an Alert
31.18 -0.70  -2.20% NASDAQ Jul 31, 3:39PM BATS Real time Currency in USD
View Full Chart
ISIS Price Chart
View All Events

ISIS Events

Date Type Description
08/04/2014 10:30 EDT Misc Q2 2014 Isis Pharmaceuticals Earnings Conferecec Call
08/04/2014 Earnings Q2 2014 Isis Pharmaceuticals Earnings Results. Estimate: -0.12.
05/06/2014 11:30 EDT Misc Isis Pharmaceuticals 1Q2014 Earning Conference Call
05/06/2014 Earnings Isis Pharmaceuticals 1Q2014 Earning Result. Estimate: -0.21.
02/28/2014 11:30 EDT Misc Isis Pharmaceuticals Q4 2013 Earning Conference Call
02/28/2014 Earnings Isis Pharmaceuticals Q4 2013 Earning Result. Estimate: -0.17.
11/05/2013 11:30 EDT Misc Webcast Alert: Isis Pharmaceuticals' Third Quarter 2013 Financial Results Conference Call
11/05/2013 Earnings Webcast Alert: Isis Pharmaceuticals' Third Quarter 2013 Financial Results. Estimate: -0.26.
09/09/2013 11:30 EDT Misc Isis Pharmaceuticals Conference Call to Discuss Its New Strategic Collaboration With Biogen Idec
08/06/2013 11:30 EDT Misc Webcast Alert: Isis Pharmaceuticals' Second Quarter 2013 Financial Results Conference Call
View All Performance Charts

ISIS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Isis Pharmaceuticals is up 9.94% over the last year vs S&P 500 Total Return up 17.22%, Biogen Idec up 54.58%, and Revance Therapeutics up N/A.

Get Quote for

PDF Report for ISIS

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ISIS Pro Report PDF
Advertisement

Portfolio Strategies Featuring ISIS

Did Isis Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ISIS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.isispharm.com
  • IR Website: http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Isis Pharmaceuticals is engaged in antisense drug discovery and development, exploiting a novel drug discovery platform it created to generate a broad pipeline of first-in-class drugs.

ISIS Excel Add-In Codes

  • Name: =YCI("ISIS","name")
  • Description: =YCI("ISIS","description")
  • Sector: =YCI("ISIS","sector")
  • Industry: =YCI("ISIS","industry")
  • Est. Current Fiscal Year End: =YCI("ISIS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.